Daniel Wiznia, MD, is an orthopedic surgeon who specializes in total hip replacement and total knee replacement. He utilizes robotic- and computer-navigated total joint replacement surgery, with an emphasis on minimally invasive and tissue-preserving procedures.
Dr. Wiznia is the co-director of the Avascular Necrosis Program, and specializes in personalized 3D targeted stem cell treatments of avascular necrosis and osteonecrosis of the femoral head. For treatment of avascular necrosis, Dr. Wiznia has co-developed a computer navigated personalized treatment utilizing a 3D model of the osteonecrotic lesion and targeting the lesion in a 3D space using a computer. Dr. Wiznia coordinates hyperbaric oxygen treatments with co-director Rummana Aslam, MBBS, with the goal of merging evidence-based regenerative medicine with novel surgical techniques.
He treats each new patient as a partner in deciding what type of surgery is best for his or her situation. “I make sure patients fully understand their condition and their options, and I work with them every step of the way,” he says. “My ultimate goal is to return patients to the activities that they enjoy and to improve their quality of life,” he says.
An associate professor of Orthopaedics & Rehabilitation at Yale School of Medicine, Dr. Wiznia has developed research programs in osteonecrosis of the femoral head, total joint replacement, health care policy, and injury prevention. His findings have been reported in many professional peer-reviewed publications, and his research has been presented at regional and national meetings.
